Advanced search
Publication Cover
Hematology Volume 28, 2023 - Issue 1
Submit an article Journal homepage
2,052
Views
0
CrossRef citations to date
0
Altmetric
Case Report

A case of KAT6A syndrome with a newly discovered mutation in the KAT6A gene, mainly manifested as bone marrow failure syndrome

Qi Aia Department of Hematology & Oncology, Tianjin Children’s Hospital, Tianjin, People’s Republic of ChinaORCID Iconhttps://orcid.org/0000-0002-6501-3051View further author information
ORCID Icon,
Lihua Jianga Department of Hematology & Oncology, Tianjin Children’s Hospital, Tianjin, People’s Republic of ChinaView further author information
,
Yun Chena Department of Hematology & Oncology, Tianjin Children’s Hospital, Tianjin, People’s Republic of ChinaView further author information
,
Xiuyun Yaoa Department of Hematology & Oncology, Tianjin Children’s Hospital, Tianjin, People’s Republic of ChinaView further author information
,
Jing Yinb Department of Rheumatology & Immunology, Tianjin Children’s Hospital, Tianjin, People’s Republic of ChinaORCID Iconhttps://orcid.org/0000-0002-2049-6774View further author information
ORCID Icon &
Sen Chena Department of Hematology & Oncology, Tianjin Children’s Hospital, Tianjin, People’s Republic of ChinaCorrespondence[email protected]
View further author information
Article: 2182159 | Received 28 Aug 2022, Accepted 12 Feb 2023, Published online: 07 Mar 2023

References

  • Zhou C, Liu W, Duan Y. MOZ/KAT6A: a promising target for acute myeloid leukemia therapy. Future Sci. 2020;12(9):759–761.
  • Yang X-J. MOZ and MORF acetyltransferases: Molecular interaction, animal development and human disease. Biochim Biophys Acta (BBA)-Mol Cell Res. 2015;1853(8):1818–1826.
  • Millan F, Cho MT, Retterer K, et al. Whole exome sequencing reveals de novo pathogenic variants in KAT6A as a cause of a neurodevelopmental disorder. Am J Med Genet Part A. 2016;170(7):1791–1798.
  • Urreizti R, Lopez-Martin E, Martinez-Monseny A, et al. The challenges of living with and managing epidermolysis bullosa: insights from patients and caregivers. Orphanet J Rare Dis. 2020;15(1):1–14.
  • A. Gauthier-Vasserot, C. Thauvin-Robinet, A.L. Bruel, Y. Duffourd, J. St-Onge, T. Jouan, J.B. Rivière, D. Heron, J. Donadieu, C. Bellanné-Chantelot, Application of whole-exome sequencing to unravel the molecular basis of undiagnosed syndromic congenital neutropenia with intellectual disability, Am J Med Genet Part A. 2017;173(1:62–71.
  • Kennedy J, Goudie D, Blair E, et al. KAT6A syndrome: genotype–phenotype correlation in 76 patients with pathogenic KAT6A variants. Genet Med. 2019;21(4):850–860.
  • Smith C, Harris J. Sleep, behavior, and adaptive function in KAT6A syndrome. Brain Sci. 2021;11(8):966.
  • Li Q, Wang K. InterVar: clinical interpretation of genetic variants by the 2015 ACMG-AMP guidelines. Am J Human Genet. 2017;100(2):267–280.
  • Teo JT, Klaassen R, Fernandez CV, et al. Clinical and genetic analysis of unclassifiable inherited bone marrow failure syndromes. Pediatrics. 2008;122(1):e139–e148.
  • Sheikh BN, Yang Y, Schreuder J, et al. MOZ (KAT6A) is essential for the maintenance of classically defined adult hematopoietic stem cells. Blood. J Am Soc Hematol. 2016;128(19):2307–2318.
  • Xie W, Hu S, Xu J, et al. Acute myeloid leukemia with t(8;16)(p11.2;p13.3)/KAT6A-CREBBP in adults; 16)(p11. 2; p13. 3)/KAT6A-CREBBP in Adults. Ann Hematol. 2019;98(5):1149–1157.
  • Tham E, Lindstrand A, Santani A, et al. Dominant mutations in KAT6A cause intellectual disability with recognizable syndromic features. Am J Human Genet. 2015;96(3):507–513.
  • Champagne N, Bertos NR, Pelletier N, et al. Identification of a human histone acetyltransferase related to monocytic leukemia zinc finger protein. J Biol Chem. 1999;274(40):28528–28536.
  • Pelletier N, Champagne N, Stifani S, et al. MOZ and MORF histone acetyltransferases interact with the Runt-domain transcription factor Runx2. Oncogene. 2002;21(17):2729–2740.
  • Trinh J, Hüning I, Yüksel Z, et al. A KAT6A variant in a family with autosomal dominantly inherited microcephaly and developmental delay. J Hum Genet. 2018;63(9):997–1001.
  • Kelley RI. KAT6A syndrome: deficiency of a histone acetyltransferase as the cause of mild to severe mitochondrial disease. Am J Med Genet Part A. 2019;179(4):729–730.
  • Arboleda VA, Lee H, Dorrani N, et al. De novo nonsense mutations in KAT6A, a lysine acetyl-transferase gene, cause a syndrome including microcephaly and global developmental delay. Am J Human Genet. 2015;96(3):498–506.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.